Overview

A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2025-09-25

Target enrollment:

Participant gender:

Summary

This study will assess the effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the effect of Erythromycin on AZD5004 in healthy adult male and female participants.

Phase:

PHASE1

Details

Lead Sponsor:

AstraZeneca

Treatments:

Atorvastatin
Erythromycin
repaglinide
Rosuvastatin Calcium
Simvastatin